Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers
Phase 1
Terminated
- Conditions
- COVID-19 ImmunisationProtection Against COVID-19 and Infections With SARS-CoV- 2COVID-19
- First Posted Date
- 2021-03-09
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- Takis
- Target Recruit Count
- 68
- Registration Number
- NCT04788459
- Locations
- 🇮🇹
San Gerardo Hospital, Monza, Italy
🇮🇹Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy
🇮🇹INMI Lazzaro Spallanzani, Rome, Italy
News
No news found